果糖二磷酸钠联合黄芪注射液治疗小儿病毒性心肌炎的疗效观察

The Efficacy of FDP Combined Astragalus Treatment Children with Viral Myocarditis

目的观察果糖二磷酸钠联合黄芪注射液治疗小儿病毒性心肌炎的临床疗效。方法 52例小儿病毒性心肌炎患儿随机分为观察组和对照组两组各26例,两组常规治疗包括应用COA(辅酶A)、KCl、肌肝、维生素C3等,观察组在上述基础上予果糖二磷酸钠口服液进行治疗,比较两组的疗效及对心功能的影响。结果观察组的总有效率明显高于对照组(χ2=8.341,P<0.05)。两组治疗后的CK、CK-MBLDH、cTnI均较治疗前明显降低(P<0.05),且观察组降低程度较对照组更明显(P<0.05)。结论果糖二磷酸钠联合黄芪注射液对小儿病毒性心肌炎疗效确切,可以明显改善患儿的心功能,值得临床推广应用。

Objective To observe the clinical efficacy of FDP combined Astragalus treatment children with viral myocarditis. Methods All 52 cases children with viral myocarditis were randomly divided into two groups and a control group of 26 patients, 26 patients observed the application of treatment, the control group 26 cases in conventional thearpy treatment, to compare the two groups, effect on cardiac function. Results The total effective rate of A group was significantly higher than B group （ X 2= 8.341, P 〈 0.05 ）. After treatment, the CK, CK-MBLDH, cTnI was significantly lower than before treatment （P 〈 0.05 ）. And the level of reducing the observation group was significantly better than the control group （ P 〈 0.05 ）. Conclusion FDP joint Astragalus on viral myocarditis in children is effective, can significantly improve cardiac function in children, worthy of clinical application.